Canada Markets close in 1 hr 12 mins
  • S&P/TSX

    17,967.91
    +23.03 (+0.13%)
     
  • S&P 500

    3,798.72
    +30.47 (+0.81%)
     
  • DOW

    30,943.98
    +129.72 (+0.42%)
     
  • CAD/USD

    0.7855
    +0.0010 (+0.1241%)
     
  • CRUDE OIL

    52.92
    +0.56 (+1.07%)
     
  • BTC-CAD

    46,105.56
    -355.65 (-0.77%)
     
  • CMC Crypto 200

    713.54
    -1.66 (-0.23%)
     
  • GOLD FUTURES

    1,837.00
    +7.10 (+0.39%)
     
  • RUSSELL 2000

    2,149.31
    +26.11 (+1.23%)
     
  • 10-Yr Bond

    1.0920
    -0.0050 (-0.46%)
     
  • NASDAQ

    13,182.82
    +184.32 (+1.42%)
     
  • VOLATILITY

    22.86
    -1.48 (-6.08%)
     
  • FTSE

    6,712.95
    -7.70 (-0.11%)
     
  • NIKKEI 225

    28,633.46
    +391.25 (+1.39%)
     
  • CAD/EUR

    0.6475
    -0.0015 (-0.23%)
     

Epinephrine Autoinjector Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 | Technavio

·4 min read

The epinephrine autoinjector market is poised to grow by USD 762.51 million during 2020-2024, progressing at a CAGR of over 7% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201203005850/en/

Technavio has announced its latest market research report titled Global Epinephrine Autoinjector Market 2020-2024 (Graphic: Business Wire)

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the epinephrine autoinjector market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the increasing prevalence of allergies.

The epinephrine autoinjector market analysis includes end-user segment, dosage segment, and geography landscape. This study identifies the technological advances as one of the prime reasons driving the epinephrine autoinjector market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The epinephrine autoinjector market covers the following areas:

Epinephrine Autoinjector Market Sizing
Epinephrine Autoinjector Market Forecast
Epinephrine Autoinjector Market Analysis

Companies Mentioned

  • Adamis Pharmaceuticals Corp.

  • ALK-Abello AS

  • Amneal Pharmaceuticals Inc.

  • Bausch Health Companies Inc.

  • kaleo Inc.

  • Lincoln Medical Ltd.

  • Mylan NV

  • Novartis AG

  • Pfizer Inc.

  • Teva Pharmaceutical Industries Ltd.

Related Reports on Health Care Include:

Global Diabetic Pens Market: The diabetic pens market size has the potential to grow by USD 3.41 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth. To get extensive research insights: Click and Get FREE Sample Report in Minutes!

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Force Summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Dosage

  • Market segments

  • Comparison by Dosage

  • 0.30gm - Market size and forecast 2019-2024

  • 0.15gm - Market size and forecast 2019-2024

  • 0.50gm - Market size and forecast 2019-2024

  • Market opportunity by Dosage

Market Segmentation by Age Group

  • Market segmentation by Age Group

Market Segmentation by End-user

  • Hospitals and clinics

  • Individuals

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Volume driver – demand-led growth

  • Market challenges

  • Market trends

Vendor Landscape

  • Vendor landscape

  • Landscape disruption

  • Competitive Scenario

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Adamis Pharmaceuticals Corp.

  • ALK-Abello AS

  • Amneal Pharmaceuticals Inc.

  • Bausch Health Companies Inc.

  • kaleo Inc.

  • Lincoln Medical Ltd.

  • Mylan NV

  • Novartis AG

  • Pfizer Inc.

  • Teva Pharmaceutical Industries Ltd.

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201203005850/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/